Madrigal Pharmaceuticals, Inc. (MDGL)
511.84
-4.90
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
0.00 (0.00%)
After-Hours: 20:00
Madrigal Pharmaceuticals Total Assets (Quarterly) : 1.245B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.245B |
| March 31, 2026 | 1.227B |
| December 31, 2025 | 1.260B |
| September 30, 2025 | 1.362B |
| June 30, 2025 | 1.015B |
| March 31, 2025 | 996.63M |
| December 31, 2024 | 1.042B |
| September 30, 2024 | 1.073B |
| June 30, 2024 | 1.100B |
| March 31, 2024 | 1.082B |
| December 31, 2023 | 640.55M |
| September 30, 2023 | 237.96M |
| June 30, 2023 | 302.46M |
| March 31, 2023 | 332.45M |
| December 31, 2022 | 362.57M |
| September 30, 2022 | 158.64M |
| June 30, 2022 | 216.39M |
| March 31, 2022 | 222.66M |
| December 31, 2021 | 273.33M |
| September 30, 2021 | 304.70M |
| June 30, 2021 | 327.96M |
| March 31, 2021 | 309.73M |
| December 31, 2020 | 287.00M |
| September 30, 2020 | 339.62M |
| June 30, 2020 | 388.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 411.46M |
| December 31, 2019 | 442.06M |
| September 30, 2019 | 456.25M |
| June 30, 2019 | 469.82M |
| March 31, 2019 | 479.56M |
| December 31, 2018 | 485.43M |
| September 30, 2018 | 489.55M |
| June 30, 2018 | 491.53M |
| March 31, 2018 | 183.48M |
| December 31, 2017 | 192.31M |
| September 30, 2017 | 62.83M |
| June 30, 2017 | 68.07M |
| March 31, 2017 | 40.36M |
| December 31, 2016 | 41.21M |
| September 30, 2016 | 41.51M |
| June 30, 2016 | 44.94M |
| March 31, 2016 | 52.97M |
| December 31, 2015 | 0.3636M |
| September 30, 2015 | 91.01M |
| June 30, 2015 | 101.54M |
| March 31, 2015 | 79.39M |
| December 31, 2014 | 100.68M |
| September 30, 2014 | 123.66M |
| June 30, 2014 | 115.95M |
| March 31, 2014 | 82.18M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.103B |
| PTC Therapeutics, Inc. | 3.250B |
| Protagonist Therapeutics, Inc. | 885.54M |
| Exelixis, Inc. | 2.494B |
| Karyopharm Therapeutics, Inc. | 111.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 720.92M |
| Shareholders Equity (Quarterly) | 523.72M |
| Debt to Equity Ratio | 0.664 |
| Current Ratio | 3.205 |
| Net Debt Paydown Yield | -0.37% |